MoneyWorks4Me

Parmax Pharma informs about board meeting outcome

12 Nov 2022 Evaluate

Parmax Pharma has informed about Outcome of the Board meeting and approval of Unaudited Financial statements for quarter and half year ended 30th September, 2022.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..